Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.52 |
| ▸ | RECQL | P46063 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | RAD52 | P43351 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | APEX1 | P27695 | 2/20 | 0.48 |
| ▸ | GAPDH | P04406 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | AGO2 | Q9UKV8 | 1/20 | 0.46 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL265021 | 0.80 | TAAR1 (0.47) | TAAR1RECQLTDP1MEN1RAD52 | |
| SCHEMBL19064575 | 0.80 | TAAR1 (0.48) | TAAR1RECQLTDP1MEN1RAD52 | |
| SCHEMBL29597839 | 0.80 | TAAR1 (0.48) | TAAR1RECQLTDP1MEN1RAD52 | |
| SCHEMBL272405 | 0.80 | TYR (0.48) | — | |
| SCHEMBL633722 | 0.80 | ESR2 (0.40) | TDP1MEN1KMT2AKDM4EMAPT | |
| SCHEMBL29531687 | 0.79 | TAAR1 (0.68) | TAAR1RECQLTDP1MEN1RAD52 | |
| SCHEMBL68660 | 0.79 | TAAR1 (0.68) | TAAR1RECQLTDP1MEN1RAD52 | |
| Hydrochloric Acid SCHEMBL19385313 | 0.79 | TAAR1 (0.47) | TAAR1RECQLTDP1MEN1RAD52 | |
| Hydrochloric Acid SCHEMBL3572840 | 0.78 | KDM4E (0.41) | TDP1MEN1KMT2AKDM4EMAPT | |
| SCHEMBL30045892 | 0.78 | KDM4E (0.43) | TDP1MEN1KMT2AKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10259894-B1 | Oxygen permeable polymers, ionomers and methods of making the same | NISSAN NORTH AMERICA, INC. (US) | 2019-04-16 | — | — | US | claimed |
| US-20190092882-A1 | Oxygen Permeable Monomers, Polymers and Ionomers and Methods of Making the Same | NISSAN MOTOR CO., LTD. (JP) | 2019-03-28 | — | — | US | claimed |
| CN-118745137-A | Diamine monomer and polyimide containing polyphenol, and preparation methods and applications thereof | 天津科技大学 | 2024-10-08 | — | — | CN | disclosed |
| CN-118745139-A | Diamine monomer and polyimide containing flexible side chains, and preparation methods and applications thereof | 天津科技大学 | 2024-10-08 | — | — | CN | disclosed |
| US-10259894-B1 | Oxygen permeable polymers, ionomers and methods of making the same | NISSAN NORTH AMERICA, INC. (US) | 2019-04-16 | — | — | US | disclosed |
| US-20190092882-A1 | Oxygen Permeable Monomers, Polymers and Ionomers and Methods of Making the Same | NISSAN MOTOR CO., LTD. (JP) | 2019-03-28 | — | — | US | disclosed |
| US-20160372339-A1 | SEMICONDUCITIVE CATECHOL GROUP ENCAPSULANT ADHESION PROMOTER FOR A PACKAGED ELECTRONIC DEVICE | NXP USA, INC. | 2016-12-22 | — | — | US | disclosed |
| US-9466544-B2 | Semiconducitive catechol group encapsulant adhesion promoter for a packaged electronic device | FREESCALE SEMICONDUCTOR, INC. (US) | 2016-10-11 | — | — | US | disclosed |
| US-20140210063-A1 | SEMICONDUCITIVE CATECHOL GROUP ENCAPSULANT ADHESION PROMOTER FOR A PACKAGED ELECTRONIC DEVICE | NXP, B.V. F/K/A FREESCALE SEMICONDUCTOR, INC. (NL) | 2014-07-31 | — | — | US | disclosed |
| US-20070190187-A1 | FORMULATION FOR ENHANCED DELIVERY OF PHENETHYLAMINE | KNELLER BRUCE W | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070190187-A1 | FORMULATION FOR ENHANCED DELIVERY OF PHENETHYLAMINE | MAOB, PNMT, MAOA | TAAR1 333/4885RECQL 2937/4885TDP1 1014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.